long-acting


Also found in: Thesaurus.
Related to long-acting: long-acting thyroid stimulator

long-acting

adj
(Pharmacology) (of a drug) slowly effective after initial dosage, but maintaining its effects over a long period of time, being slowly absorbed and persisting in the tissues before being excreted. Compare intermediate-acting, short-acting
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.long-acting - active over a long period of time
long - primarily temporal sense; being or indicating a relatively great or greater than average duration or passage of time or a duration as specified; "a long life"; "a long boring speech"; "a long time"; "a long friendship"; "a long game"; "long ago"; "an hour long"
References in periodicals archive ?
(Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') will launch Etak Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent Etak on August 29, 2019 at pharmacies and drugstores countrywide.
M2 PHARMA-August 23, 2019-ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every Two Months
ViiV Healthcare, a company majority owned by GSK (GS), with Pfizer (PFE), and Shionogi Limited as shareholders, announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen, or 2DR, of ViiV Healthcare's cabotegravir and Janssen's rilpivirine for the treatment of HIV.
Long-acting insulin plus sulfonylurea and age 75 years or older were negatively associated with hypoglycemia.
If approved, this long-acting, injectable regimen of cabotegravir and rilpivirine has the potential to give people living with HIV one month between doses with similar safety and efficacy as today's standard of care-an oral, 3-drug regimen taken everyday.
New use of inhaled long-acting beta, agonists or long-acting antimuscarinic antagonists was associated with a 1.5-fold increased cardiovascular risk within 30 days of initiation in patients with chronic obstructive pulmonary disease, irrespective of prior cardiovascular disease status and history of exacerbations, according to a review of more than 280,000 COPD patients in Taiwan.
That approach came as news to many meeting attendees, based on results of an audience poll in which 76% of attendees picked triple therapy for a 65-year-old male with COPD and frequent exacerbations who was taking only a long-acting muscarinic antagonist (LAMA).
That approach came as news to many internists, at least going by results of an audience poll in which 76% of attendees picked triple therapy for a 65-year-old male with COPD and frequent exacerbations despite having used a long-acting muscarinic antagonist (LAMA).
The product is a fixed-dose LAMA/LABA combination of the long-acting muscarinic antagonist (LAMA) aclidinium and the long-acting beta agonist (LABA) formoterol, administered via a PRESSAIR multi-dose inhaler.
Ultibro Breezhaler is an inhaled once-daily fixed-dose combination of indacaterol (a long-acting beta 2 agonist; LABA) and glycopyrronium bromide (a long-acting muscarinic antagonist; LAMA) and Seebri Breezhaler is an inhaled fixed-dose formulation of glycopyrronium bromide (a long-acting muscarinic antagonist; LAMA).
ViiV Healthcare presented comprehensive 48-week data from the ATLAS (Antiretroviral Therapy as Long-Acting Suppression) and FLAIR (First Long-Acting Injectable Regimen) pivotal phase III studies of the novel, investigational, long-acting regimen of cabotegravir and rilpivirine.